ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 272 filers reported holding ICU MED INC in Q3 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $841,296 | -24.5% | 5,100 | -31.1% | 0.00% | -33.3% |
| Q3 2022 | $1,114,000 | -23.0% | 7,400 | -15.9% | 0.00% | -25.0% |
| Q2 2022 | $1,447,000 | -75.4% | 8,800 | -66.7% | 0.00% | -75.0% |
| Q1 2022 | $5,878,000 | +50.1% | 26,400 | +60.0% | 0.02% | +60.0% |
| Q4 2021 | $3,916,000 | -43.1% | 16,501 | -44.1% | 0.01% | -44.4% |
| Q3 2021 | $6,885,000 | +126.0% | 29,501 | +99.3% | 0.02% | +125.0% |
| Q2 2021 | $3,046,000 | -14.8% | 14,800 | -14.9% | 0.01% | -20.0% |
| Q1 2021 | $3,575,000 | -45.5% | 17,400 | -43.1% | 0.01% | -44.4% |
| Q4 2020 | $6,564,000 | +70.2% | 30,601 | +45.0% | 0.02% | +63.6% |
| Q3 2020 | $3,856,000 | -21.6% | 21,100 | -21.0% | 0.01% | -21.4% |
| Q2 2020 | $4,921,000 | -0.4% | 26,701 | +9.0% | 0.01% | -26.3% |
| Q1 2020 | $4,943,000 | +11.5% | 24,500 | +3.4% | 0.02% | +90.0% |
| Q4 2019 | $4,435,000 | +1501.1% | 23,700 | +2054.5% | 0.01% | +900.0% |
| Q2 2019 | $277,000 | -46.4% | 1,100 | -51.2% | 0.00% | 0.0% |
| Q4 2018 | $517,000 | -81.3% | 2,253 | -76.9% | 0.00% | -85.7% |
| Q3 2018 | $2,758,000 | +93.5% | 9,754 | +100.9% | 0.01% | +75.0% |
| Q2 2018 | $1,425,000 | +196.3% | 4,854 | +54.0% | 0.00% | +100.0% |
| Q1 2017 | $481,000 | +10.6% | 3,152 | +6.8% | 0.00% | 0.0% |
| Q4 2016 | $435,000 | -85.8% | 2,952 | -87.8% | 0.00% | -84.6% |
| Q3 2016 | $3,065,000 | -46.5% | 24,254 | -52.3% | 0.01% | -55.2% |
| Q2 2016 | $5,734,000 | -20.4% | 50,854 | -26.5% | 0.03% | -27.5% |
| Q1 2016 | $7,199,000 | -18.5% | 69,154 | -11.7% | 0.04% | -24.5% |
| Q4 2015 | $8,836,000 | -8.0% | 78,349 | -10.6% | 0.05% | -13.1% |
| Q3 2015 | $9,609,000 | +25.8% | 87,654 | +9.8% | 0.06% | +3.4% |
| Q2 2015 | $7,639,000 | -8.1% | 79,854 | -10.5% | 0.06% | -7.8% |
| Q1 2015 | $8,313,000 | +3.0% | 89,255 | -9.4% | 0.06% | -1.5% |
| Q4 2014 | $8,072,000 | +90.4% | 98,555 | +49.2% | 0.06% | +97.0% |
| Q3 2014 | $4,239,000 | -20.0% | 66,055 | -24.2% | 0.03% | -19.5% |
| Q2 2014 | $5,300,000 | -23.5% | 87,155 | -24.6% | 0.04% | -34.9% |
| Q1 2014 | $6,925,000 | +32.3% | 115,655 | +40.8% | 0.06% | +23.5% |
| Q4 2013 | $5,235,000 | +43.6% | 82,155 | +53.1% | 0.05% | +18.6% |
| Q3 2013 | $3,645,000 | +542.9% | 53,655 | +583.1% | 0.04% | +437.5% |
| Q2 2013 | $567,000 | – | 7,855 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |